Long-Acting Injectable Risperidone for Relapse Prevention and Control of Breakthrough Symptoms After a Recent First Episode of Schizophrenia: A Randomized Clinical Trial

IMPORTANCE: Long-acting, injectable, second-generation antipsychotic medication has tremendous potential to bring clinical stability to persons with schizophrenia. However, long-acting medications are rarely used following a first episode of schizophrenia. OBJECTIVE: To compare the clinical efficacy...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Psychiatry
Main Authors: Subotnik, Kenneth L., Casaus, Laurie R., Ventura, Joseph, Luo, John S., Hellemann, Gerhard S., Gretchen-Doorly, Denise, Marder, Stephen, Nuechterlein, Keith H.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5065351/
https://ncbi.nlm.nih.gov/pubmed/26107752
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamapsychiatry.2015.0270
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados